FK778 attenuates cytomegalovirus-enhanced vein graft intimal hyperplasia in a rat model

Intervirology

Volumn 52, Issue 4, 2009, Pages 189-195

  Kloppenburg, Geoffrey ^a,b   De Graaf, Rick ^a   Grauls, Gert ^a   Bruggeman, Cathrien A ^a   Van Hooff, Johannes P ^a   Stassen, Frank ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Cytomegalovirus; FK778; Intima hyperplasia; Vein graft

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT FAILURE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VEIN GRAFT;

ALKYNES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; HERPESVIRIDAE INFECTIONS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MALE; MUROMEGALOVIRUS; NITRILES; RATS; TRANSPLANTS; TUNICA INTIMA;

CYTOMEGALOVIRUS; RATTUS;

EID: 67449138479     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225194     Document Type: Article

References (28)

1. LoGerfo FW, Quist WC, Cantelmo NL, et al: Integrity of vein grafts as a function of initial intimal and medial preservation. Circulation 1983; 68:II117-II124.
2. Horne BD, Muhlestein JB, Strobel GG, et al; Intermountain Heart Collaborative (IHC) Study Group: Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 2002; 144: 491-500.
3. Mueller C, Hodgson JM, Bestehorn HP, et al: Cytomegalovirus infection and restenosis after aggressive angioplasty with provisional stenting. J Interv Cardiol 2003; 16: 307-313.
4. Zhou YF, Leon MB, Waclawiw MA, et al: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 29; 335: 624-630. (Pubitemid 26277952)
5. Kloppenburg G, de Graaf R, Herngreen S, et al: Cytomegalovirus aggravates intimal hyperplasia in rats by stimulating smooth muscle cell proliferation. Microbes Infect 2005; 7: 164-170. (Pubitemid 40387420)
6. Bartels C, Maass M, Bein G, et al: Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts. Circulation 1999; 99: 879-882.
7. Bartels C, Maass M, Bein G, et al: Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease. Circulation 2000; 101: 137-141.
8. Ibrahim AI, Obeid MT, Jouma MJ, et al: Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 2005; 32: 29-32. (Pubitemid 39575012)
9. Limnell V, Pasternack R, Karjalainen J, et al: Seropositivity for Helicobacter pylori antibodies is associated with lower occurrence of venous bypass graft occlusion. Scand J Infect Dis 2004; 36: 601-603.
10. Vincenti F: What's in the pipeline? New immunosuppressive drugs in transplantation. Am J Transplant 2002; 2: 898-903. (Pubitemid 36330218)
11. Silva HT Jr, Cao W, Shorthouse RA, et al: In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis. Transplant Proc 1997; 29: 1292-1293.
12. Kurrle R, Bartlett R, Ruuth E, et al: Malononitrilamides inhibit T- and B-cell responsiveness. Transplant Proc 1996; 28: 3053-3056.
13. Deuse T, Schrepfer S, Schafer H, et al: FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies. Transplantation 2004; 78: 71-77. (Pubitemid 38938286)
14. Savikko J, Von Willebrand E, Hayry P: Leflunomide analogue FK778 is vasculoprotective independent of its immunosuppressive effect: potential applications for restenosis and chronic rejection. Transplantation 2003; 76: 455-458. (Pubitemid 37013246)
15. Czech J, Kurrle R, Schorlemmer HU: The antiproliferative effect of malononitrilamides on vascular smooth muscle cells is antagonized by exogenous uridine. Inflamm Res 1999; 48(suppl 2):S128-S129. (Pubitemid 30020080)
16. Evers DL, Wang X, Huong SM, et al: Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778. Antiviral Res 2005; 65: 1-12. (Pubitemid 40094769)
17. Waldman WJ, Knight DA, Lurain NS, et al: Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation 1999; 68: 814-825. (Pubitemid 29468200)
18. Waldman WJ, Knight DA, Blinder L, et al: Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999; 42: 412-418. (Pubitemid 30122078)
19. Hoch JR, Stark VK, Hullett DA, et al: Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 1994; 116: 463-470.
20. Bruggeman CA, Meijer H, Dormans PH, et al: Isolation of a cytomegalovirus-like agent from wild rats. Arch Virol 1982; 73: 231-241. (Pubitemid 13216326)
21. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54: 589-599. (Pubitemid 15132717)
22. McKechnie NM, Gurr W, Braun G: Immunization with the cross-reactive antigens Ov39 from Onchocerca volvulus and hr44 from human retinal tissue induces ocular pathology and activates retinal microglia. J Infect Dis 1997; 176: 1334-1343.
23. Fitzgibbon GM, Kafka HP, Leach AJ, et al: Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28: 616-626. (Pubitemid 26288642)
24. Majesky MW, Schwartz SM, Clowes MM, et al: Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 1987; 61: 296-300.
25. Speir E, Modali R, Huang ES, et al: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-394. (Pubitemid 24259971)
26. Persoons MC, Daemen MJ, Bruning JH, et al: Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis? Circ Res 1994; 75: 214-220.
27. Jahnke T, Schafer FK, Bolte H, et al: 2005 Dr. Gary J. Becker Young Investigator Award: periprocedural oral administration of the leflunomide analogue FK778 inhibits neo-intima formation in a double-injury rat model of restenosis. J Vasc Interv Radiol 2005; 16: 903-910.
28. Pan F, Ebbs A, Wynn C, et al: FK778, a powerful new immunosuppressant, effectively reduces functional and histological changes of chronic rejection in rat renal allografts. Transplantation 2003; 75: 1110-1114. (Pubitemid 36513004)